Jack Legler

Dr. Jack Legler

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2023 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
JLJack Legler
Jack Legler
CLCarl Laverdiere
Carl Laverdiere
MBMathieu Boily
Mathieu Boily
MTMagdalena Tarchala
Magdalena Tarchala
AHAdam Hart
Adam Hart
PMPaul A. Martineau
Paul A. Martineau

8 February 2025 in Journal of Hand and Microsurgery
Verified
Journal Article
Closed access
OSOmar El Sewify
Omar El Sewify
SDShaishav Datta
Shaishav Datta
JLJack Legler
Jack Legler
MSMarion Sylvain
Marion Sylvain
ACAndre Cheah
Andre Cheah
JEJohnny Ionut Efanov
Johnny Ionut Efanov

17 February 2026 in Journal of Children's Orthopaedics
Verified
Journal Article
Open access
PMPeter Joseph Mounsef
Peter Joseph Mounsef
JLJack Legler
Jack Legler
DPDev Patel
Dev Patel
RHReggie Hamdy
Reggie Hamdy
Purpose: Telescoping intramedullary rods have transformed the management of long bone deformity and fragility fractures in children, yet complications and revision surgery remain common. This systematic review synthesizes outcomes across telescoping systems to evaluate complication and revision rates, telescoping success, and design evolution to guide implant selection and surgical decision-making in pediatric orthopedics. Methods: A search was conducted through July 2025 following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies reporting outcomes of telescoping rods in pediatric patients were included. Due to heterogeneity, results were synthesized descriptively and presented as weighted means per operated bone. Results: Thirty-three studies (861 patients; 2054 rods) were included. Weighted mean complication and revision rates were 49.6% and 25.7% for Bailey-Dubow rods, 61.1% and 24.5% for Sheffield rods, 37.1% and 30.5% for Fassier-Duval rods, 14.9% and 9.0% for corkscrew-locking rods, and 46.7% and 6.7% for distal-female rods. Telescoping success was 48% for Bailey-Dubow, 74% for Fassier-Duval, 94% for corkscrew, and 100% for distal-female designs. Variation in follow-up duration and definitions of complications contributed to differences in reported rates. Conclusions: Modern telescoping rods have reduced migration and mechanical failure compared with earlier designs, yet complication and revision rates remain substantial. Newer systems show encouraging early results but require longer follow-up for validation. Differences in bone anatomy and biomechanics strongly influence implant performance, underscoring the need to tailor rod selection to individual bones. Significance: This review consolidates published complication and revision rates across telescoping rod designs, establishing a foundation for comparison as newer implants are introduced and long-term outcome data become available. Level of Evidence: III.

23 April 2025 in Journal of Pediatric Orthopaedics
Verified
Journal Article
Closed access
JLJack Legler
Jack Legler
LBLee. R. Benaroch
Lee. R. Benaroch
APAli Ahmadi Pirshahid
Ali Ahmadi Pirshahid
OSOlivia Bsc Serhan
Olivia Bsc Serhan
DCDraydon Bsc Cheng
Draydon Bsc Cheng
PTPatrick Thornley
Patrick Thornley
Background: Hereditary multiple osteochondromas (HMO) is a common pediatric condition defined by multiple cartilage-capped bony lesions. Spinal osteochondromas affect up to 68% of HMO patients. Although most are asymptomatic, intraspinal osteochondromas can cause significant neurological symptoms and morbidity. Limited guidelines exist regarding the use of advanced imaging to screen for spinal osteochondromas. This study evaluates the incidence of spinal osteochondromas detected through advanced imaging in pediatric HMO patients. Methods: A systematic review and meta-analysis were conducted following the Cochrane Handbook for Systematic Reviews of Interventions. Included studies reported on the use of computed tomography (CT) or magnetic resonance imaging (MRI) in HMO patients under the age of 21. The primary outcome was spinal osteochondroma incidence. Secondary outcomes included imaging indication, symptoms, intraspinal lesion incidence, surgical intervention incidence, and postoperative outcomes. A meta-analysis of single proportions determined the pooled incidence of spinal osteochondromas, intraspinal lesions, and spinal surgery in HMO patients. Results: Of 415 eligible articles, seven met inclusion criteria, including 198 HMO patients with a weighted mean age of 12 ± 1.0 years. MRI was the primary imaging modality in 175 patients (99%) with 136 (69%) imaged only per institutional screening protocols. Neurological symptoms were present in 41 subjects (21%) at the time of imaging. The pooled spinal osteochondroma incidence was 36% (95% CI, 24%–51%, event rate 72/183). Of these, 109 lesions (43%) were in the cervical spine, 41 lesions (38%) in the thoracic spine, and 21 lesions (19%) in the lumbar spine. Among those with spinal osteochondromas, 49% (95% CI, 37%–61%, event rate 41/85) had intraspinal lesions, and 21% (95% CI, 13%–33%, event rate 15/70) underwent surgery. Postoperatively, 17 patients (55%) experienced symptom resolution with no long-term complications reported. Conclusions: Although spinal osteochondromas are prevalent among HMO patients, standardized screening protocols remain limited. Nonetheless, initial and serial screening is needed to prevent irreversible neurological damage. As global guidelines evolve, large multicentre prospective studies are needed to identify and standardize optimal timing for spinal osteochondroma screening in HMO patients. Level of Evidence: Level III.

1 January 2024 in Strategies in Trauma and Limb Reconstruction
Verified
Journal Article
Open access
MBMitchell Bernstein
Mitchell Bernstein
JLJack Legler
Jack Legler
SMSimon Martel
Simon Martel
PMPascal Mailhot
Pascal Mailhot
To describe a surgical technique for the safe removal of a broken non-cannulated PRECICE bone transport nail (NuVasive Specialized Orthopedics) without compromising limb reconstruction. The removal of broken non-cannulated intramedullary lengthening nails (IMLNs) is challenging. Few techniques have been described for the safe removal of these devices without compromising bone salvage. A 42-year-old male presented for complex right tibia reconstruction following a type IIIB open tibia fracture with a 92-mm bone defect. The bone defect was initially managed with an all-internal bone transport nail system (PRECICE bone transport). At the 13-month follow-up, the patient presented with a broken lengthening nail, varus limb deformity, and nonunion at the docking site. The nail components were extracted sequentially, and a burr hole was created in the distal segment of the nail through the nonunion site to facilitate removal. The residual varus deformity and tibial shaft nonunion were managed with a hexapod frame. The IMLN was successfully removed without compromising limb reconstruction. By sequentially removing the components of the nail and altering the distal portion of the implant through the nonunion site, safe removal of the implant without further bone loss was achieved. This report describes an efficient technique for the removal of broken non-cannulated IMLNs when extractors are not available. Legler J, Martel S, Mailhot P, et al. Extraction of a Broken PRECICE Bone Transport System: A Case Report and Technique for Residual Limb Salvage. Strategies Trauma Limb Reconstr 2024;19(3):171–176.

3 August 2026 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
PDF file
JLJack Legler
Jack Legler
SMSamuel Morgan
Samuel Morgan
PBPaul Beaulé
Paul Beaulé
HAHesham Abdelbary
Hesham Abdelbary
GGGeorge Grammatopoulos
George Grammatopoulos
SGSimon Garceau
Simon Garceau
Introduction : Recent work in total knee arthroplasty (TKA) prosthetic joint infection (PJI) suggests that timing from hospital admission to DAIR (debridement, antibiotic, and implant retention) is a modifiable risk factor influencing treatment outcomes. The study assessed the impact of timing from admission to DAIR on clinical outcomes and treatment success in the total hip arthroplasty (THA) PJI population. Methods : A retrospective review was conducted at a specialized PJI tertiary referral centre. Patients who underwent DAIR for THA PJI between 2008 and 2021 with a minimum 2-year follow-up were included. The primary outcome was reoperation for recalcitrant PJI. Secondary outcomes included 90 d readmission, 90 d and 1-year mortality, and postoperative complications. Multivariate regression analysis identified factors associated with DAIR outcomes. Results : A total of 100 patients satisfied the inclusion criteria. The mean time from admission to DAIR was 46.4 ± 45.1 h, and 52.0 % required reoperation for recalcitrant PJI. Prolonged time from admission to DAIR was associated with increased 90 d mortality (odds ratio or OR: 1.02, CI (confidence interval) 95 %: 1.00–1.03, p = 0.04). Increasing age was associated with greater 1-year mortality (OR: 1.06, CI 95 %: 1.00–1.12, p = 0.049). McPherson host grade C compared to grade A was associated with both greater 1-year mortality (OR: 12.75, CI 95 %: 1.11–146.09, p = 0.04) and postoperative complications (OR: 7.59, CI 95 %: 1.22–47.08, p = 0.03). McPherson extremity grade II versus grade I (OR: 3.28, CI 95 %: 1.21–8.92, p = 0.02) and revision THAs (OR: 0.15, CI 95 %: 0.03–0.72, p = 0.02) were associated with postoperative complications. Lower haemoglobin levels (OR: 1.04, CI 95 %: 1.01–1.07, p = 0.004) were associated with higher reoperation risk. Conclusion : In a DAIR-treated cohort, increased time from admission to surgery was associated with greater 90 d mortality in THA PJI patients. Timely surgical intervention and optimization of modifiable risk factors are essential to improve outcomes.